Deflafit 30mg Tablet
By Deflafit
Rx
6 Tablet in a Strip

Composition
Deflazacort(30mg)

Manufacturer - Intas Pharmaceuticals Ltd
Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad - 380009. Gujarat. India.

Expires on or after
September, 2026

liver
Deflafit 30mg Tablet is considered safe for use in patients with liver disease. It is important to note that no dose adjustment of Deflafit 30mg Tablet is necessary for individuals with liver issues. This means that patients with liver disease can generally take Deflafit 30mg Tablet without needing to change the dosage. However, it is still advised to proceed with caution and monitor for any adverse effects while using this medication. If you have any concerns or questions regarding the use of Deflafit 30mg Tablet in relation to your liver health, it is always best to consult with your doctor for proper guidance.

kidney
Deflafit 30mg Tablet is considered safe for patients with kidney disease. No dosage adjustment is necessary.

alcohol
Do not drink alcohol while taking Deflafit 30mg Tablet.

driving
Deflafit 30mg Tablet generally does not impact driving ability.

pregnancy
Deflafit 30mg Tablet may not be safe during pregnancy. Animal studies indicate potential harm to the baby. Consult your doctor as risks and benefits need to be considered before use.

breastfeeding
Deflafit 30mg Tablet may not be safe to use while breastfeeding. Limited evidence indicates it might pass into breastmilk, potentially harming the baby. It is advisable to consult a doctor before using this medication during breastfeeding.
Habit Forming | No |
Chemical Class | Gluco/mineralocorticoids, progestogins and derivatives |
Therapeutic Class | HORMONES |
Action Class | - |
₹208.8
₹232
10% OFF
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 18-Nov-2024